
Have you seen blood in your urine or felt pain in your flank? IgA nephropathy, also known as Berger disease or IGAN, is a serious kidney issue. It affects millions but often goes unnoticed until it’s too late.
At Liv Hospital, we use the latest technology and care deeply for our patients. We aim to help you understand this complex disease. We’ll work with you to create a treatment plan that keeps your kidneys healthy.
IgA nephropathy happens when IgA antibodies build up in the kidneys’ filtering units. This causes inflammation and can harm your kidneys.
Key Takeaways
- IgA nephropathy is a major cause of kidney problems and failure globally.
- The condition is marked by IgA antibodies in the kidneys.
- It’s vital for both patients and doctors to grasp IgA nephropathy to manage it well.
- Liv Hospital provides detailed care and tailored treatment plans for IgA nephropathy patients.
- Early diagnosis and treatment are key to safeguarding your kidney health and avoiding complications.
Understanding IgA Nephropathy: Causes and Mechanisms

It’s important to know how IgA nephropathy works to find good treatments. This kidney disease is caused by IgA antibodies in the kidneys. These antibodies can damage the kidneys over time.
The Immune System’s Role
The immune system is key in IgA nephropathy. It makes a special IgA called galactose-deficient IgA1 (Gd-IgA1). This IgA is seen as foreign by the body.
The body then makes antibodies against Gd-IgA1. These antibodies form complexes that stick together in the kidneys. This causes inflammation and damage to the kidneys.
The production of Gd-IgA1 and the immune response are central to the pathogenesis of IgA nephropathy. Studies show that B cells and T cells play a big role. They help make Gd-IgA1 and form immune complexes.
Global Prevalence and Demographic Patterns
IgA nephropathy is a worldwide problem. It affects different people in different ways. The exact number of cases is hard to know because it’s often not diagnosed right away.
| Population | Incidence Rate (per 100,000) |
| East Asian | 4-5 |
| European | 2-3 |
| North American | 1-2 |
People from East Asia and the Pacific Islands get IgA nephropathy more often. This shows that genetics play a big role in the disease.
Knowing who is most at risk helps doctors treat IgA nephropathy better. By focusing on high-risk groups, doctors can screen and treat more effectively. This could lead to better health outcomes for those with the disease.
How IgA Nephropathy Affects Your Kidneys

IgA antibodies can cause inflammation in the kidneys. This leads to damage and affects how well the kidneys work. If not treated, it can cause serious kidney problems over time.
Damage to the Glomerular Filtration System
The glomerular filtration system is key for removing waste and extra fluids. IgA Nephropathy damages this system by depositing IgA antibodies. This damage causes hematuria (blood in the urine) and proteinuria (too much protein in the urine).
The inflammation from IgA Nephropathy can scar the glomeruli. This makes it hard for them to filter waste. As the disease gets worse, kidney function can decline. This might lead to chronic kidney disease or kidney failure.
Signs and Symptoms of Kidney Dysfunction
The symptoms of kidney problems from IgA Nephropathy vary. Common signs include:
- Urine that is pink or the color of tea or cola, often after a cold, sore throat, or respiratory infection
- Foamy urine because of too much protein
- Swelling in hands or feet
- High blood pressure
These symptoms often show up during or right after a cold or sore throat. They can also get worse with an upper respiratory infection. Catching IgA Nephropathy early and treating it is key to slowing its progress and keeping the kidneys working well.
Diagnosis, Treatment, and Management
Getting an accurate diagnosis and effective treatment is vital for slowing IgA Nephropathy’s progression. Doctors use a mix of clinical checks, lab tests, and sometimes a kidney biopsy to diagnose this condition.
Diagnostic Approaches
Diagnosing IgA Nephropathy involves several steps. Blood tests check kidney function, urine tests look for protein or blood, and a kidney biopsy examines tissue damage. These steps help doctors understand the kidney damage and decide on treatment.
Blood tests measure waste products like creatinine and urea to check kidney function. Urine tests find abnormalities like blood and protein in the urine, common in IgA Nephropathy.
A kidney biopsy is key for a definitive diagnosis. It lets doctors see kidney tissue under a microscope and confirm IgA deposits in the glomeruli.
Treatment Strategies and Long-term Outlook
Treatment for IgA Nephropathy aims to slow kidney damage, manage symptoms, and prevent complications. New treatments have improved the outlook for patients.
Medications are essential in managing IgA Nephropathy. They include:
- ACE inhibitors or ARBs to control blood pressure and reduce proteinuria.
- Corticosteroids to reduce inflammation.
- Immunosuppressive drugs in certain cases to suppress the immune system.
The FDA has approved new treatments like Fabhalta (iptacopan), Vanrfia (atrasentan), and Tarpeyo (budesonide). These offer more options for patients.
Managing IgA Nephropathy well requires regular check-ups and adjusting treatment plans as needed. This helps slow disease progression and improves quality of life.
Conclusion
IgA nephropathy, also known as Berger kidney disease, is a condition where the immune system damages the kidneys. It’s important to understand the causes, like ga nephropathy causes, to manage it well.
Managing IgA nephropathy means ongoing care and monitoring. This includes watching kidney function and managing symptoms. Knowing about IgA nephropathy helps patients and doctors work together to improve health.
Managing IgA nephropathy requires a full approach. This includes understanding the condition, its symptoms, and treatment options. Together, patients with idney disease iga can live active lives and reduce risks of complications.
FAQ
What is IgA nephropathy?
IgA nephropathy is a kidney disease where the antibody immunoglobulin A (IgA) builds up in the glomeruli, causing inflammation and impaired filtration.
What causes IgA nephropathy?
The exact cause is unknown, but it involves abnormal IgA deposits triggered by immune system dysfunction, infections, or genetic factors.
What are the symptoms of IgA nephropathy?
Symptoms can include blood in the urine, proteinuria, swelling in the hands or feet, high blood pressure, and occasional kidney pain.
How is IgA nephropathy diagnosed?
Diagnosis is made through urine tests, blood tests, and confirmed with a kidney biopsy showing IgA deposits.
What are the treatment options for IgA nephropathy?
Treatment focuses on controlling blood pressure, reducing proteinuria with ACE inhibitors or ARBs, immunosuppressants in severe cases, and lifestyle management.
Can IgA nephropathy lead to kidney failure?
Yes, over years, chronic inflammation can lead to scarring and potentially progress to end-stage kidney disease in some patients.
How does IgA nephropathy affect the glomerular filtration system?
IgA deposits cause inflammation and scarring in the glomeruli, reducing their ability to filter blood effectively.
Is IgA nephropathy a common condition?
It is one of the most common primary glomerular diseases worldwide, especially in young adults.
What is the long-term outlook for patients with IgA nephropathy?
Outlook varies; many have mild disease with slow progression, while 20–40% may develop kidney failure over decades.
How can IgA nephropathy be managed?
Management includes blood pressure control, proteinuria reduction, healthy diet, regular monitoring, and in severe cases, immunosuppressive therapy.
References
National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6627351/